A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus

This study has been completed.

Sponsor:

Hoffmann-La Roche

ClinicalTrials.gov Identifier:

NCT01042769

First Posted: January 6, 2010

Last Update Posted: November 2, 2016

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.